Title : Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp).

Pub. Date : 2006 Jul

PMID : 16252067






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp). Cyclosporine ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus
2 Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp). Cyclosporine ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus
3 Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp). Cyclosporine ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus
4 Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp). Cyclosporine ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus
5 These results pointed to a pharmacokinetic drug interaction between CsA and amisulpride most likely caused by inhibition of P-gp. Cyclosporine ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus